Data available on the extent of cocaine use and dependence: Biochemistry, pharmacologic effects and global burden of disease of cocaine abusers

Current Medicinal Chemistry

Volumn 19, Issue 33, 2012, Pages 5647-5657

  Pomara, C ^a   Cassano, T ^b   D'Errico, S ^a   Bello, S ^a   Romano, A D ^a   Riezzo, I ^a   Serviddio, G ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Institute of Pharmacology   (Italy)

Author keywords

"Crack"; Cardiovascular disease; Cocaine abuse; Dependence; Epidemiology; Laws restricting

Indexed keywords

COCAINE;

ACCIDENTAL INJURY; ARTICLE; BACTERIAL INFECTION; BIOCHEMISTRY; BLOODSTREAM INFECTION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; COCAINE DEPENDENCE; GEOGRAPHIC DISTRIBUTION; HUMAN; LAW; LEGAL ASPECT; LIVER CIRRHOSIS; MENTAL DISEASE; MUCOSA; NORTH AMERICA; VIOLENCE; VIRUS INFECTION;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; HUMANS; LUNG;

EID: 84871324372     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803988811     Document Type: Article

References (133)

1. De Wit, D. J.; Hance, J.; Offord, D. R.; Ogborne, A, The influence of early and frequent use of marijuana on the risk of desistance and of progression to marijuana-related harm. Prev Med, 2000, 31, (5), 455-464.
2. Anthony, J. C.; Petronis, K. R., Early-onset drug use and risk of later drug problems. Drug Alcohol Depend, 1995, 40, (1), 9-15.
3. J, G. M.a. C. Drug use, drug abuse and heterogeneity. United Nations publication, 2002.
4. Van Etten, M. L.; Anthony, J. C., Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin. Drug Alcohol Depend, 1999, 54, (2), 117-125.
5. Kandel, D. B.; Johnson, J. G.; Bird, H. R.; Weissman, M. M.; Goodman, S. H.; Lahey, B. B.; Regier, D. A.; Schwab-Stone, M. E., Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study. Journal of the American Academy of Child and Adolescent Psychiatry, 1999, 38, (6), 693-699.
6. Kendler, K. S.; Prescott, C. A., Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry, 1998, 155, (9699687), 1016-1022.
7. Yamaguchi, K.; Kandel, D. B., Patterns of drug use from adolescence to young adulthood: III. Predictors of progression. Am J Public Health, 1984, 74, (6742253), 673-681.
8. National Institute on Drug Abuse. Epidemiologic Trends in Drug Abuse. Proceedings of the Community Epidemiology Work Group, Highlights and Executive Summary. http://archives.drugabuse.gov/pdf/cewg/Vol1-1203.pdf (Accessed May 18, 2012)
9. The influence of epidemiology on drug control policy, Bulletin on Narcotics. 10. D. F. Musto and Z. Sloboda. (United Nations publication), vol. LV, Nos. 1 and 2. http://www.unodc.org/pdf/bulletin/bulletin-2003-01-01-1.pdf (Accessed May 18, 2012)
10. Epidemiology and policy: the post-war context, Bulletin on Narcotics. V. Berridge. (United Nations publication), vol. LIV, Nos. 1 and 2(2002), pp. 143-151. http://www.unodc.org/pdf/bulletin/bulletin-2002-01-01-1.pdf (Accessed May 18, 2012)
11. Weinberg, N. Z.; Rahdert, E.; Colliver, J. D.; Glantz, M. D., Adolescent substance abuse: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry, 1998, 37, (9519629), 252-261.
12. Hawkins, J. D.; Catalano, R. F.; Miller, J. Y., Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull, 1992, 112, (1529040), 64-6105.
13. Pandina, R. J. In National Conference on Drug Abuse Prevention Research: Presentations, Papers, and Recommendations; National Institutes of Health publication 1998; Vol. No. 98-4293, pp 17-26.
14. Bry, B. H.; McKeon, P.; Pandina, R. J., Extent of drug use as a function of number of risk factors. J Abnorm Psychol, 1982, 91, (4), 273-279.
15. Drug abuse epidemiology: an overview", Z. Sloboda, Bulletin on Narcotics, vol. LIV, Nos 1 and 2, 2002. http://www.unodc.org/pdf/bulletin/ bulletin 2002 01 01 Art1.pdf (Accessed May 18, 2012)
16. World Health Organization, Guide to drug abuse epidemiology. http://whqlibdoc.who.int/hq/2000/a58352-PartA.pdf (Accessed May18, 2012)
17. Glantz M, S. Z. In Resilience and Development: Positive Life Adaptations. Glantz M, J. J., Ed.; Kluwer Academic/Plenum Press Publishers: New York, 1999, pp 109-126.
18. Washton, A. M.; Gold, M. S.; Pottash, A. C., 'Crack'. Early report on a new drug epidemic. Postgrad Med, 1986, 80, (5), 52-54, 57-58.
19. Smart, R. G., "Crack" cocaine use in Canada: a new epidemic? Am J Epidemiol, 1988, 127, (3369429), 1315-1317.
20. Strang, J.; Griffiths, P.; Gossop, M., Crack and cocaine use in south London drug addicts: 1987-1989. Br J Addict, 1990, 85, (2317585), 193-196.
21. World Health Organization Regional Office for Europe.. Smoking, drinking and drug taking in the european region, Copenhagen. http://www.euro.who.int/- data/assets/pdf-file/0007/68065/E74573.pdf (Accessed May 18, 2012)
22. Medina-Mora, M. E., Rojas, E., Galva, J., Berenzon, S., Carreno, S., Juarwz, F., Villatoro, J., and Lopez, E, Consumo de sustancias con efectos psicotropicos en la poblacion estudiantil de ensenanza media y media superior de la Republica Mexicana. Salud Mental, 1993, 16, 2-8.
23. Castro, M. E., Valencia, M., Consumo de drogas en Mexico. Patrones de uso en la poblacion escolar. Salud Publica de Mexico, 1978, 21, 585-590.
24. The epidemiology of cocaine use and abuse. Shober, S and Schade, C. National Institute on drug abuse. http://archives.drugabuse.gov/pdf/monographs/ 110.pdf (Accessed May 18, 2012)
25. European Monitoring Centre for Drugs and Drug addiction (EMCDDA). Annual Report 2009: the state of the drugs problem in Europe. Lisbon: EMCDDA. http://www.emcdda.europa.eu/publications/annual-report/2009 (Accessed May 18, 2012)
26. Taylor, R. F.; Bernard, G. R., Airway complications from free-basing cocaine. Chest, 1989, 95, (2), 476-477.
27. Scott, D. B., "Maximum recommended doses" of local anaesthetic drugs. Br J Anaesth, 1989, 63, (4), 373-374.
28. Keung, Y. K.; Morgan, D.; Cobos, E., Cocaine-induced microangiopathic hemolytic anemia and thrombocytopenia simulating thrombotic thrombo cytopenia purpura. Ann Hematol, 1996, 72, (3), 155-156.
29. Prakash, A.; Das, G., Cocaine and the nervous system. Int J Clin Pharmacol Ther Toxicol, 1993, 31, (12), 575-581.
30. Maurer, H. H.; Sauer, C.; Theobald, D. S., Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther Drug Monit, 2006, 28, (3), 447-453.
31. Kovacic, P., Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Med Hypotheses, 2005, 64, (2), 350-356.
32. Dean, R. A.; Christian, C. D.; Sample, R. H.; Bosron, W. F., Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J, 1991, 5, (12), 2735-2739.
33. Brzezinski, M. R.; Spink, B. J.; Dean, R. A.; Berkman, C. E.; Cashman, J. R.; Bosron, W. F., Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metab Dispos, 1997, 25, (9), 1089-1096.
34. Laizure, S. C.; Mandrell, T.; Gades, N. M.; Parker, R. B., Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab Dispos, 2003, 31, (1), 16-20.
35. Kreek, M. J.; Bart, G.; Lilly, C.; La Forge, K. S.; Nielsen, D. A., Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev, 2005, 57, (1), 1-26.
36. Verstraete, A. G., Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit, 2004, 26, (2), 200-205.
37. Toennes, S. W.; Kauert, G. F., Importance of vacutainer selection in forensic toxicological analysis of drugs of abuse. J Anal Toxicol, 2001, 25, (5), 339-343.
38. Staack, R. F.; Theobald, D. S.; Paul, L. D.; Springer, D.; Kraemer, T.; Maurer, H. H., Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug pmethoxymethamphetamine. Drug Metab Dispos, 2004, 32, (4), 379-381.
39. Brock, A.; Brock, V., Plasma cholinesterase activity in a healthy population group with no occupational exposure to known cholinesterase inhibitors: relative influence of some factors related to normal inter-and intra-individual variations. Scand J Clin Lab Invest, 1990, 50, (4), 401-408.
40. Lukas, S. E.; Sholar, M.; Lundahl, L. H.; Lamas, X.; Kouri, E.; Wines, J. D.; Kragie, L.; Mendelson, J. H., Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology (Berl), 1996, 125, (4), 346-354.
41. Kloss, M. W.; Rosen, G. M.; Rauckman, E. J., N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Mol Pharmacol, 1983, 23, (2), 482-485.
42. Nassogne, M. C.; Evrard, P.; Courtoy, P. J., Selective direct toxicity of cocaine on fetal mouse neurons. Teratogenic implications of neurite and apoptotic neuronal loss. Ann N Y Acad Sci, 1998, 846, 51-68.
43. Wieczorek, W. J.; Kruk, Z. L., A quantitative comparison on the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of re-uptake in the caudate putamen and nucleus accumbens in the rat brain slice. Brain Res, 1994, 657, (1-2), 42-50.
44. Ross, S. B.; Renyi, A. L., Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur J Pharmacol, 1969, 7, (3), 270-277.
45. Heikkila, R. E.; Orlansky, H.; Cohen, G., Studies on the distinction between uptake inhibition and release of (3H) dopamine in rat brain tissue slices. Biochem Pharmacol, 1975, 24, (8), 847-852.
46. Hadfield, M. G.; Mott, D. E.; Ismay, J. A., Cocaine: effect of in vivo administration on synaptosomal uptake of norepinephrine. Biochem Pharmacol, 1980, 29, (12), 1861-1863.
47. Johanson, C. E.; Fischman, M. W., The pharmacology of cocaine related to its abuse. Pharmacol Rev, 1989, 41, (1), 3-52.
48. Brown, J. M.; Hanson, G. R.; Fleckenstein, A. E., Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther, 2001, 296, (3), 762-767.
49. Venton, B. J.; Seipel, A. T.; Phillips, P. E.; Wetsel, W. C.; Gitler, D.; Greengard, P.; Augustine, G. J.; Wightman, R. M., Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci, 2006, 26, (12), 3206-3209.
50. Jatlow, P.; McCance, E. F.; Bradberry, C. W.; Elsworth, J. D.; Taylor, J. R.; Roth, R. H., Alcohol plus cocaine: the whole is more than the sum of its parts. Ther Drug Monit, 1996, 18, (4), 460-464.
51. Shanti, C. M.; Lucas, C. E., Cocaine and the critical care challenge. Crit Care Med, 2003, 31, (6), 1851-1859.
52. Goldstein, R. A.; Des Lauriers, C.; Burda, A. M., Cocaine: history, social implications, and toxicity-a review. Dis Mon, 2009, 55, (1), 6-38.
53. Volkow, N. D.; Fowler, J. S.; Wang, G. J., The addicted human brain: insights from imaging studies. J Clin Invest, 2003, 111, (10), 1444-1451.
54. Degenhardt, L.; Hall, W., Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet, 2012, 379, (9810), 55-70.
55. Vicente J, G. I., Matias J, Hedrich D, Wiessing L., Rebound of overdose mortality in the European Union 2003-2005: findings from the 2008 EMCDDA Annual Report. Euro Surveill. 2009, 2009, 14, (2), 4-5.
56. Lucena, J.; Blanco, M.; Jurado, C.; Rico, A.; Salguero, M.; Vazquez, R.; Thiene, G.; Basso, C., Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J, 2010, 31, (3), 318-329.
57. Zuccato, E.; Castiglioni, S.; Tettamanti, M.; Olandese, R.; Bagnati, R.; Melis, M.; Fanelli, R., Changes in illicit drug consumption patterns in 2009 detected by wastewater analysis. Drug Alcohol Depend, 2011, 118, (2-3), 464-469.
58. Dipartimento Politiche Antidroga, Presidenza del Consiglio dei Ministri, 2010. Relazione annuale al Parlamento sull'uso di sostanze stupefacenti e sulle tossicodipendenze in Italia. Rome, Italy. http://www.governo. it GovernoInforma/Dossier/relazione tossicodipendenze 2010/relazione 2010 2.pdf (Accessed May 18, 2012).
59. Molinaro, S.; Siciliano, V.; Curzio, O.; Denoth, F.; Salvadori, S.; Mariani, F., Illegal substance use among Italian high school students: trends over 11 years (1999-2009). PLoS One, 2011, 6, (21695199).
60. Costes, J. M., La cocaïne en France: Une nette progression au cours des dix dernières années. Revue Toxibase, 2006, 21, 6-8.
61. Phénomènes émergents liés à l'usage de drogues en France en 2003: Principaux résultats du cinquième rapport national. Bello, P Y. Tendances n 40. http://bdoc.ofdt.fr/pmb/opac-css/ doc-num.php?explnum-id=8092 (Accessed May 18, 2012)
62. Fort, E.; Massardier-Pilonchery, A.; Facy, F.; Bergeret, A., Prevalence of drug use in French seamen. Addictive behaviors, 2012, 37, (3), 335-338.
63. United Nations Office of Drugs and Crime, 2009. The World Drug Report 2009. United Nations, New York. http://www.unodc.org/documents/wdr/WDR-2009/ WDR2009-eng-web.pdf (Accessed May 18, 2012)
64. National Advisory Committee on Drugs. An Overview of Cocaine Use in Ireland II. Dublin: The Stationery Office, 2007. http://www.nacd.ie/ publications/Overview-Cocaine-Use-2.pdf (Accessed May 18, 2012)
65. Galvin, S.; Campbell, M.; Marsh, B.; O'Brien, B., Cocaine-related admissions to an intensive care unit: a five-year study of incidence and outcomes. Anaesthesia, 2010, 65, (19930217), 163-166.
66. Nuijten, M.; Blanken, P.; van den Brink, W.; Hendriks, V., Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the Netherlands. BMC Psychiatry, 2011, 11, (21854580), 135-135.
67. Johnston, L. D.; O'Malley, P. M.; Bachman, J. G.; Schulenberg, J. E.; Educational Resources Information Center (U. S.); University of Michigan Institute for Social Research.; Distributed by ERIC Clearinghouse: [S.l.], 2011, p 84 p.
68. a Substance Abuse and Mental Health Services Administration, Results from the 2009 National Survey on Drug Use and Health: Volume I, Summary of National Findings, 2010, Rockville, Maryland, USA.
69. Health Canada, Canadian Alcohol and Drug Use Monitoring Survey. 2009.
70. Boehrer, J. D.; Moliterno, D. J.; Willard, J. E.; Snyder, R. W., 2nd; Horton, R. P.; Glamann, D. B.; Lange, R. A.; Hillis, L. D., Hemodynamic effects of intranasal cocaine in humans. J Am Coll Cardiol, 1992, 20, (1), 90-93.
71. Foltin, R. W.; Ward, A. S.; Haney, M.; Hart, C. L.; Collins, E. D., The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend, 2003, 70, (2), 149-157.
72. Resnick, R. B.; Kestenbaum, R. S.; Schwartz, L. K., Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. Science, 1977, 195, (4279), 696-698.
73. Muscholl, E., Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen. Br J Pharmacol Chemother, 1961, 16, 352-359.
74. Feldman, J. A.; Fish, S. S.; Beshansky, J. R.; Griffith, J. L.; Woolard, R. H.; Selker, H. P., Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial. Ann Emerg Med, 2000, 36, (5), 469-476.
75. McCord, J.; Jneid, H.; Hollander, J. E.; de Lemos, J. A.; Cercek, B.; Hsue, P.; Gibler, W. B.; Ohman, E. M.; Drew, B.; Philippides, G.; Newby, L. K., Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation, 2008, 117, (14), 1897-1907.
76. Mouhaffel, A. H.; Madu, E. C.; Satmary, W. A.; Fraker, T. D., Jr., Cardiovascular complications of cocaine. Chest, 1995, 107, (5), 1426-1434.
77. Qiu, Z.; Wang, J.; Perreault, C. L.; Meuse, A. J.; Grossman, W.; Morgan, J. P., Effects of endothelin on intracellular Ca2+ and contractility in single ventricular myocytes from the ferret and human. Eur J Pharmacol, 1992, 214, (2-3), 293-296.
78. Mittleman, M. A.; Mintzer, D.; Maclure, M.; Tofler, G. H.; Sherwood, J. B.; Muller, J. E., Triggering of myocardial infarction by cocaine. Circulation, 1999, 99, (21), 2737-2741.
79. Minor, R. L., Jr.; Scott, B. D.; Brown, D. D.; Winniford, M. D., Cocaineinduced myocardial infarction in patients with normal coronary arteries. Ann Intern Med, 1991, 115, (10), 797-806.
80. Dressler, F. A.; Malekzadeh, S.; Roberts, W. C., Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol, 1990, 65, (5), 303-308.
81. Apostolakis, E.; Tsigkas, G.; Baikoussis, N. G.; Koniari, I.; Alexopoulos, D., Acute left main coronary artery thrombosis due to cocaine use. J Cardiothorac Surg, 2010, 5, 65.
82. Mongeon, F. P.; Rinfret, S., Left main coronary artery occlusion with myocardial infarction in a cocaine user. Successful angioplasty with a drugeluting stent. Can J Cardiol, 2008, 24, (5), e30-32.
83. Heesch, C. M.; Wilhelm, C. R.; Ristich, J.; Adnane, J.; Bontempo, F. A.; Wagner, W. R., Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart, 2000, 83, (6), 688-695.
84. Pradhan, L.; Mondal, D.; Chandra, S.; Ali, M.; Agrawal, K. C., Molecular analysis of cocaine-induced endothelial dysfunction: role of endothelin-1 and nitric oxide. Cardiovasc Toxicol, 2008, 8, (4), 161-171.
85. Jonas, M. A.; Oates, J. A.; Ockene, J. K.; Hennekens, C. H., Statement on smoking and cardiovascular disease for health care professionals. American Heart Association. Circulation, 1992, 86, (5), 1664-1669.
86. Virmani, R.; Robinowitz, M.; Smialek, J. E.; Smyth, D. F., Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J, 1988, 115, (5), 1068-1076.
87. Kloner, R. A.; Hale, S.; Alker, K.; Rezkalla, S., The effects of acute and chronic cocaine use on the heart. Circulation, 1992, 85, (2), 407-419.
88. Serviddio, G.; Bellanti, F.; Romano, A. D.; Tamborra, R.; Rollo, T.; Altomare, E.; Vendemiale, G., Bioenergetics in aging: mitochondrial proton leak in aging rat liver, kidney and heart. Redox. Rep., 2007, 12, (1), 91-95.
89. Remondino, A.; Kwon, S. H.; Communal, C.; Pimentel, D. R.; Sawyer, D. B.; Singh, K.; Colucci, W. S., Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun. NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res, 2003, 92, (2), 136-138.
90. Daras, M.; Tuchman, A. J.; Koppel, B. S.; Samkoff, L. M.; Weitzner, I.; Marc, J., Neurovascular complications of cocaine. Acta Neurol Scand, 1994, 90, (2), 124-129.
91. Bahar, M.; Cole, G.; Rosen, M.; Vickers, M. D., Histopathology of the spinal cord after intrathecal cocaine, bupivacaine, lignocaine and adrenaline in the rat. Eur J Anaesthesiol, 1984, 1, (3), 293-297.
92. Jacobs, I. G.; Roszler, M. H.; Kelly, J. K.; Klein, M. A.; Kling, G. A., Cocaine abuse: neurovascular complications. Radiology, 1989, 170, (1 Pt 1), 223-227.
93. Klonoff, D. C.; Andrews, B. T.; Obana, W. G., Stroke associated with cocaine use. Arch Neurol, 1989, 46, (9), 989-993.
94. Johnson, B.; Lamki, L.; Fang, B.; Barron, B.; Wagner, L.; Wells, L.; Kenny, P.; Overton, D.; Dhother, S.; Abramson, D.; Chen, R.; Kramer, L., Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography. Neuropsychopharmacology, 1998, 18, (5), 377-384.
95. Rogers, K. J.; Nahorski, S. R., Depression of cerebral metabolism by stimulant doses of cocaine. Brain Res, 1973, 57, (1), 255-258.
96. London, E. D.; Cascella, N. G.; Wong, D. F.; Phillips, R. L.; Dannals, R. F.; Links, J. M.; Herning, R.; Grayson, R.; Jaffe, J. H.; Wagner, H. N., Jr., Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry, 1990, 47, (6), 567-574.
97. Konzen, J. P.; Levine, S. R.; Garcia, J. H., Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke, 1995, 26, (6), 1114-1118.
98. Kaye, B. R.; Fainstat, M., Cerebral vasculitis associated with cocaine abuse. Jama, 1987, 258, (15), 2104-2106.
99. Petty, G. W.; Brust, J. C.; Tatemichi, T. K.; Barr, M. L., Embolic stroke after smoking "crack" cocaine. Stroke, 1990, 21, (11), 1632-1635.
100. Devenvi, P.; McDonough, M. A., Cocaine abuse and endocarditis. Ann Intern Med, 1988, 109, (1), 82-83.
101. Cregler, L. L.; Mark, H., Medical complications of cocaine abuse. The New England journal of medicine, 1986, 315, (23), 1495-1500.
102. Kelley, P. A.; Sharkey, J.; Philip, R.; Ritchie, I. M., Acute cocaine alters cerebrovascular autoregulation in the rat neocortex. Brain Res Bull, 1993, 31, (5), 581-585.
103. Tashkin, D. P., Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med, 2001, 7, (2), 43-61.
104. Mayo-Smith, M. F.; Spinale, J., Thermal epiglottitis in adults: a new complication of illicit drug use. J Emerg Med, 1997, 15, (4), 483-485.
105. Forrester, J. M.; Steele, A. W.; Waldron, J. A.; Parsons, P. E., Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis, 1990, 142, (2), 462-467.
106. Tashkin, D. P.; Kleerup, E. C.; Koyal, S. N.; Marques, J. A.; Goldman, M. D., Acute effects of inhaled and i.v. cocaine on airway dynamics. Chest, 1996, 110, (4), 904-910.
107. Bailey, M. E.; Fraire, A. E.; Greenberg, S. D.; Barnard, J.; Cagle, P. T., Pulmonary histopathology in cocaine abusers. Hum Pathol, 1994, 25, (2), 203-207.
108. Kleerup, E. C.; Wong, M.; Marques-Magallanes, J. A.; Goldman, M. D.; Tashkin, D. P., Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers. Chest, 1997, 111, (1), 30-35.
109. Di Paolo, N.; Fineschi, V.; Di Paolo, M.; Wetly, C. V.; Garosi, G.; Del Vecchio, M. T.; Bianciardi, G., Kidney vascular damage and cocaine. Clin Nephrol, 1997, 47, (5), 298-303.
110. Welch, R. D.; Todd, K.; Krause, G. S., Incidence of cocaine-associated rhabdomyolysis. Ann Emerg Med, 1991, 20, (2), 154-157.
111. Lee, H. S.; La Maute, H. R.; Pizzi, W. F.; Picard, D. L.; Luks, F. I., Acute gastroduodenal perforations associated with use of crack. Ann Surg, 1990, 211, (1), 15-17.
112. Freudenberger, R. S.; Cappell, M. S.; Hutt, D. A., Intestinal infarction after intravenous cocaine administration. Ann Intern Med, 1990, 113, (9), 715-716.
113. Glauser, J.; Queen, J. R., An overview of non-cardiac cocaine toxicity. J Emerg Med, 2007, 32, (2), 181-186.
114. Degenhardt L, H. W., Lynskey M, Warner-Smith M. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. 2nd ed. World Health Organization: Geneva, 2004.
115. Degenhardt, L.; Hall, W.; Warner-Smith, M., Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect, 2006, 82 Suppl 3, (16735295), 56-63.
116. Degenhardt, L.; Bucello, C.; Mathers, B.; Briegleb, C.; Ali, H.; Hickman, M.; McLaren, J., Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction, 2011, 106, (21054613), 32-51.
117. Rossow, I.; Lauritzen, G., Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction, 1999, 94, (10396789), 209-219.
118. Lange, R. A.; Hillis, L. D., Sudden death in cocaine abusers. Eur Heart J, 2010, 31, (20071327), 271-273.
119. Petitti, D. B.; Sidney, S.; Quesenberry, C.; Bernstein, A., Stroke and cocaine or amphetamine use. Epidemiology, 1998, 9, (9799166), 596-600.
120. Vasica, G.; Tennant, C. C., Cocaine use and cardiovascular complications. Med J Aust, 2002, 177, (12197823), 260-262.
121. Cregler, L. L., Cocaine: a risk factor for cardiovascular disease in women. Cardiovascular Risk Factors. Cardiovascular Risk Factors, 1994, 4, 39-44.
122. Sbriglio R, M. R. B. In Cocaine. A Clinician's Handbook. Gold, A. M. W. M. S., Ed.; The Guildford Press: New York, 1987, pp 87-95.
123. Dackis, C. A.; O'Brien, C. P., Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat, 2001, 21, (11728784), 111-117.
124. Chen, K.; Kandel, D., Relationship between extent of cocaine use and dependence among adolescents and adults in the United States. Drug Alcohol Depend, 2002, 68, (12167553), 65-85.
125. Gossop, M.; Strang, J.; Griffiths, P.; Powis, B.; Taylor, C., A ratio estimation method for determining the prevalence of cocaine use. Br J Psychiatry, 1994, 164, (7921720), 676-679.
126. Hatsukami, D. K.; Fischman, M. W., Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? Jama, 1996, 276, (8918856), 1580-1588.
127. de Lima, M. S.; de Oliveira Soares, B. G.; Reisser, A. A. P.; Farrell, M., Pharmacological treatment of cocaine dependence: a systematic review. Addiction, 2002, 97, (12144591), 931-949.
128. Carroll, K. M. In Cocaine Treatment: Research and Clinical Perspectives. NIDA Research Monograph, Number 135. Leukefeld, T. C. G., Ed.; Department of Health and Human Services. National Institute on Drug Abuse.: Rockville, Maryland, 1993.
129. Fineschi, V.; Baroldi, G.; Centini, F.; Cerretani, D.; Fiaschi, A. I.; Micheli, L.; Parolini, M.; Turillazzi, E.; Giorgi, G., Markers of cardiac oxidative stress and altered morphology after intraperitoneal cocaine injection in a rat model. Int J Legal Med, 2001, 114, (11508797), 323-330.
130. Fineschi, V.; Silver, M. D.; Karch, S. B.; Parolini, M.; Turillazzi, E.; Pomara, C.; Baroldi, G., Myocardial disarray: an architectural disorganization linked with adrenergic stress? Int J Cardiol, 2005, 99, (15749187), 277-282.
131. Fineschi, V.; Wetli, C. V.; Di Paolo, M.; Baroldi, G., Myocardial necrosis and cocaine. A quantitative morphologic study in 26 cocaine-associated deaths. Int J Legal Med, 1997, 110, (9274943), 193-198.
132. Uniited Nations Office of Drug and Crime (UNODC). World Drug Report 2011. http://www.unodc.org/documents/data-and-analysis/WDR2011/World-Drug-Report- 2011-ebook.pdf (Accessed April 18, 2012).
133. http://www.thegooddrugsguide.com/cocaine/legality.htm (Accessed April 18, 2012).